XMRV Infection in Patients With Prostate Cancer: Novel Serologic Assay and Correlation With PCR and FISH

Arnold, Rebecca S.; Makarova, Natalia; Osunkoya, Adeboye O.; Suppiah, Suganthi; Scott, Takara A.; Johnson, Nicole; Bhosle, Sushma M.; Liotta, Dennis; Hunter, Eric; Marshall, Fray F.; Ly, Hinh; Molinaro, Ross J.; Blackwell, Jerry L.; Petros, John A.

doi:10.1016/j.urology.2010.01.038

Cited by 90 publications

(119 citation statements)

References 11 publications

Supporting

Mentioning

104

Contrasting

Order By: Relevance

“…A similar study reported, a 22% XMRV prevalence in prostate cancers from Texas but the virus was found in both tumor and non-tumor tissues (Danielson et al, 2010). Moreover neutralizing antibodies for XMRV were identified in 11 of 40 patients with prostate cancer and XMRV sequences were confirmed in five of 11 by nested PCR and fluorescence in situ hybridization (Arnold et al, 2010;Switzer et al, 2011). Recently a study reported that, XMRV was detectable in some patients with prostate cancer in Kerman, southeast of Iran (Reza et al, 2012).…”

Section: Introductionmentioning

confidence: 81%

“…A high prevalence of XMRV has been reported in patients with prostate cancer and chronic fatigue syndrome (CFS) in the USA (Urisman et al, 2006;Schlaberg et al, 2009;Arnold et al, 2010). But, in Europe (Fischer et al, 2008;Hohn et al, 2009;Verhaegh et al, 2011), the USA, and recent study in Australia detection of XMRV in prostate (Aloia et al, 2010;Switzer et al, 2010;Rezaei et al, 2013), and breast cancer tissues (Khan et al, 2012) have been failed.…”

Section: Discussionmentioning

confidence: 99%

“…Since original report, some researchers have detected XMRV in human prostate cancers, while others did not (Schlaberg et al, 2009;Arnold et al, 2010;Danielson et al, 2010;Verhaegh et al, 2011). Schlaberg et al (2009) in USA showed higher prevalence of XMRV DNA by PCR (6%) and viral proteins by immunohistochemistry (IHC) (23%) in tissues from prostate cancers in comparison to noncancerous controls (Schlaberg et al, 2009).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

No Detection of Xenotropic Murine Leukemia Virus-Related Viruses in Prostate Cancer in Sanandaj, West of Iran

Khodabandehloo

Hosseini²,

Rahmani³

et al. 2013

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Asian Pac J Cancer Prev, 14 (11), 6929-6933 IntroductionProstate cancer is the most common malignancy in men worldwide (Groom et al., 2012). The annual incidence rates of prostate cancer among Iranian population are dramatically higher than in other countries of Asia (Akbari et al., 2008). Multiple etiologies have been hypothesized for the cause of prostate cancers, including genetic defects, infectious agents and associated inflammation (Silverman et al., 2010). Identification of a potential virus as the cause of prostate cancer is very important because it could facilitate management of this disease such as treatment and prevention. A recently described retrovirus, the xenotropic murine leukemia virus-related virus (XMRV) was detected in about 40% of familial prostate cancer using a DNA microarray (Virochip) containing oligonucleotides comprising conserved sequences from known viral genomes and was strongly associated with homozygosity for the R462Q reduced activity, a variant of the antiviral enzyme, RNase L (Urisman et al., 2006).Murine leukemia viruses (MLVs) belong to gammaretroviruses in the retroviridae family, which viral RNA is reverse-transcribed to DNA during replication. They are endogenous viruses that have integrated their provirus DNA into the mouse genome and can cause leukemias, lymphomas, neurologic diseases, and has been reported to be detected in prostate cancer. However, this virus has not been detected in similar groups of patients in other studies. Herein, we sought to detect XMRV in prostate cancers and benign controls in Sanandaj, west of Iran. Materials and Methods: In a case-control study, genomic DNA was extracted from formalin fixed and paraffin embedded prostate tissues from a total of 163 Iranian patients. We developed a conventional and a nested PCR assay using primers targeting to an env specific sequence of XMRV. PCR assays were carried out on 63 prostate cancers and 100 benign prostate hyperplasias. Results: Beta-actin sequences were successfully detected in the DNA extracts from all prostate tissues, confirming DNA extraction integrity. We did not detect XMRV in samples either from prostate cancers or benign prostate hyperplasias using XMRV specific primers. Conclusions: We conclude that in our population XMRV does not play a role in genesis of prostate cancer.

show abstract

Section: Introductionmentioning

confidence: 81%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

No Detection of Xenotropic Murine Leukemia Virus-Related Viruses in Prostate Cancer in Sanandaj, West of Iran

Khodabandehloo

Hosseini²,

Rahmani³

et al. 2013

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

show abstract

“…If it can be proven that XMRV infection is indeed widespread and can cause prostate cancer and/or other human diseases (1,21,34,41), it is important to identify effective antivirals against this virus. Toward this end, recent studies have shown that HIV-1 RT inhibitors, such as azidothymidine (AZT) (33,35), zidovudine (ZDV), and tenofovir disoproxil fumarate (TDF), as well as the integrase inhibitor raltegravir (35), can inhibit XMRV replication in cell culture to various extents, suggesting that they can be used either individually or as a combination therapy to treat XMRV infection (33,35).…”

Section: Discussionmentioning

confidence: 99%

Evaluation of Cellular Determinants Required for In Vitro Xenotropic Murine Leukemia Virus-Related Virus Entry into Human Prostate Cancer and Noncancerous Cells

Bhosle¹,

Suppiah²,

Molinaro³

et al. 2010

J Virol

Self Cite

View full text Add to dashboard Cite

Prostate cancer is the most common male malignancy in Western countries and the second most common cause of cancer-related deaths in males worldwide (15,24). The known risk factors for prostate cancer are hormones (i.e., androgens), diet, sex, and race, as well as environmental and genetic factors (27). A recent study suggests that susceptibility to prostate cancer can be influenced by the genetic variations associated with an antagonistic coevolution, which occurs between a specific host locus (RNASEL), known to be involved in antiviral innate immune defense, and a viral pathogen (38). Indeed, several epidemiologic studies have supported the involvement of the RNASEL gene in the prostate cancer etiology (4,5,30,31), whereas other studies do not (9,22,34,43). Some studies have reported that individuals with a single mutated copy of the RNASEL gene have a 50% increased risk for prostate cancer, whereas those with homozygous mutant RNASEL alleles have a 2-fold-increased risk of prostate cancer (5).The RNASEL gene encodes for the RNase L protein, a constitutively expressed latent endoribonuclease, which mediates the interferon-inducible 2-5A system against viral and/or cellular double-stranded RNAs (8,16,20,23,49,50). The RNase L "Q" variant allele (R462Q) shows a 3-fold decrease in catalytic activity compared to the wild-type enzyme (5, 44). The possible association of mutant RNASEL alleles with human prostate cancers suggests an enhanced susceptibility of prostate tissues to a viral agent. This hypothesis has led to the recent identification of a new human retrovirus, xenotropic murine leukemia virus (MuLV)-related virus (XMRV), in 40% of prostate cancer patients with the QQ variant alleles of RNASEL compared to 1.5% among heterozygous (RQ) and wild-type (RR) RNASEL carriers (41). XMRV virus infection appears to be susceptible to inhibition by interferon and its downstream effector RNase L protein (7). However, a recent study has provided some evidence to show that XMRV infection is independent of the RNASEL genotype (34), suggesting that population differences and/or other environmental or genetic factors may influence the impact of RNASEL on prostate cancer development.The XMRV genome is 8,185 nucleotides in length and shares up to 95% overall nucleotide sequence identity with known xenotropic MuLVs (41). One receptor for xenotropic MuLVs is Xpr1, a 696-amino-acid protein with multiple transmembrane-spanning domains (2). Expression of this protein in Chinese hamster ovary (CHO) cells that are not known to express Xpr1 endogenously confers an enhanced susceptibility of these cells to xenotropic MuLV infection (2). Infection of hamster and mouse cells with XMRV-like virus that is derived from a prostate cancer cell line (22Rv1) also requires Xpr1 as a receptor (18). Earlier studies have demonstrated the importance of certain residues located within the putative third and fourth extracellular loops (ECL3 and ECL4) of Mus dunni's Xpr1 in conferring infection by xenotropic MuLVs (25). Furthermore, it has been shown ...

show abstract

“…A particular xenotropic MLV named xenotropic murine leukemia virus-related virus (XMRV) has been cloned from human prostate cancer tumors as well as blood samples from individuals suffering from chronic fatigue syndrome (CFS) (1,18,29,39). XMRV detection in a small percentage of samples from healthy controls suggested widespread infection (7,18,29).…”

mentioning

confidence: 99%

Phylogenetic Analysis of Murine Leukemia Virus Sequences from Longitudinally Sampled Chronic Fatigue Syndrome Patients Suggests PCR Contamination Rather than Viral Evolution

Hué

Kellam

Towers

2011

J Virol

View full text Add to dashboard Cite

Xenotropic murine leukemia virus (MLV)-related virus (XMRV) has been amplified from human prostate cancer and chronic fatigue syndrome (CFS) patient samples. Other studies failed to replicate these findings and suggested PCR contamination with a prostate cancer cell line, 22Rv1, as a likely source. MLV-like sequences have also been detected in CFS patients in longitudinal samples 15 years apart. Here, we tested whether sequence data from these samples are consistent with viral evolution. Our phylogenetic analyses strongly reject a model of within-patient evolution and demonstrate that the sequences from the first and second time points represent distinct endogenous murine retroviruses, suggesting contamination.

show abstract

XMRV Infection in Patients With Prostate Cancer: Novel Serologic Assay and Correlation With PCR and FISH

Cited by 90 publications

References 11 publications

No Detection of Xenotropic Murine Leukemia Virus-Related Viruses in Prostate Cancer in Sanandaj, West of Iran

No Detection of Xenotropic Murine Leukemia Virus-Related Viruses in Prostate Cancer in Sanandaj, West of Iran

Evaluation of Cellular Determinants Required for In Vitro Xenotropic Murine Leukemia Virus-Related Virus Entry into Human Prostate Cancer and Noncancerous Cells

Phylogenetic Analysis of Murine Leukemia Virus Sequences from Longitudinally Sampled Chronic Fatigue Syndrome Patients Suggests PCR Contamination Rather than Viral Evolution

Contact Info

Product

Resources

About